Picture of Magle Chemoswed Holding AB logo

MAGLE — Magle Chemoswed Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Sweden's Magle Chemoswed Q2 revenue rises on improved production efficiencies

Sweden's Magle Chemoswed Q2 revenue rises on improved production efficiencies


Overview

  • Sweden contract manufacturing firm's Q2 revenue rose yr/yr, EBITDA turned positive

  • Company remains loss-making due to non-recurring restructuring costs


Outlook

  • Company expects turnaround to take 12 to 18 months from initial announcement

  • Magle Chemoswed says continued operation depends on recapitalisation agreement implementation


Result Drivers

  • PRODUCTION EFFICIENCIES - Co said improved production efficiencies supported revenue recovery in Q2

  • RESTRUCTURING COSTS - Co said substantial non-recurring restructuring costs weighed on Q2 results


Company press release: ID:nMFNKkfSh


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Total Revenue

SEK 74.60 mln

Q2 Net Loss

SEK 17 mln

Q2 EBIT

-SEK 13.10 mln

Q2 EBITDA

SEK 1.50 mln


Analyst Coverage

  • Wall Street's median 12-month price target for Magle Chemoswed Holding AB is SEK3.00, about 500% above its August 10 closing price of SEK0.50

  • The stock recently traded at 0 times the next 12-month earnings vs. a P/E of 3 three months ago


Reuters Recommended Reads

  • Aug 12 - Germany's Medios H1 profit hit by pricing pressure; to buy 74% of Caelo to expand API

  • Aug 10 - Mesa Labs Q1 revenue rises as calibration, biopharma units grow


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Magle Chemoswed Holding AB

See all news